← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PATRIN · Approved 2022-02-18

Drug application

FDA Application #

ANDA212604

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

PREGABALIN

Active ingredients

PREGABALIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

PATRIN

Manufacturer

Patrin Pharma, Inc.

First approval

2022-02-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown